Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $310.7M | $329.3M | $361.1M | $298.4M | $254.6M | |
| Revenue Growth (YoY) | 10.31% | 5.96% | 9.68% | -17.37% | -14.67% | |
| Cost of Revenues | $215.1M | $256.9M | $280.7M | $230.8M | $203.7M | |
| Gross Profit | $95.6M | $72.4M | $80.4M | $67.6M | $50.9M | |
| Gross Profit Margin | 30.76% | 21.98% | 22.27% | 22.67% | 19.98% | |
| R&D Expenses | $12.6M | $15.8M | $18.2M | $18.5M | $17.3M | |
| Selling, General & Admin | $58.5M | $60.9M | $70.6M | $53.9M | $55M | |
| Other Inc / (Exp) | -$818K | -$3.3M | -$124.6M | -$52.2M | -$8.2M | |
| Operating Expenses | $86.4M | $74.6M | $75M | $75.5M | $68.4M | |
| Operating Income | $9.2M | -$2.2M | $5.4M | -$7.8M | -$17.5M | |
| Net Interest Expenses | $5.4M | $2.2M | $2M | $3.2M | $4.7M | |
| EBT. Incl. Unusual Items | $3M | -$9.8M | -$121.6M | -$63.3M | -$31.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $822K | $246K | $1.8M | -$116K | -$1.8M | |
| Net Income to Company | $2.2M | -$10.1M | -$123.3M | -$63.2M | -$29.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.2M | -$10.1M | -$123.3M | -$63.2M | -$29.3M | |
| Basic EPS (Cont. Ops) | $0.18 | -$0.75 | -$9.09 | -$4.59 | -$1.80 | |
| Diluted EPS (Cont. Ops) | $0.18 | -$0.75 | -$9.09 | -$4.59 | -$1.80 | |
| Weighted Average Basic Share | $13.1M | $13.3M | $13.6M | $13.8M | $16.3M | |
| Weighted Average Diluted Share | $13.3M | $13.3M | $13.6M | $13.8M | $16.3M | |
| EBITDA | $23.7M | $10.9M | $18.6M | $3M | -$7.6M | |
| EBIT | $8.4M | -$2.2M | $5.4M | -$7.8M | -$17.5M | |
| Revenue (Reported) | $310.7M | $329.3M | $361.1M | $298.4M | $254.6M | |
| Operating Income (Reported) | $9.2M | -$2.2M | $5.4M | -$7.8M | -$17.5M | |
| Operating Income (Adjusted) | $8.4M | -$2.2M | $5.4M | -$7.8M | -$17.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $85.9M | $89M | $66.2M | $64.5M | $47M | |
| Revenue Growth (YoY) | 9.68% | 3.71% | -25.61% | -2.6% | -27.11% | |
| Cost of Revenues | $67M | $68.7M | $52.8M | $51.2M | $38.6M | |
| Gross Profit | $18.9M | $20.4M | $13.4M | $13.3M | $8.4M | |
| Gross Profit Margin | 21.98% | 22.89% | 20.28% | 20.59% | 17.85% | |
| R&D Expenses | $4.5M | $4.6M | $4.5M | $4.1M | $2.6M | |
| Selling, General & Admin | $16.3M | $15.1M | $13.2M | $13.1M | $12.1M | |
| Other Inc / (Exp) | -$144K | $2K | -$29.7M | -$2.8M | -- | |
| Operating Expenses | $20.3M | $18.7M | $18.8M | $16.2M | $14.7M | |
| Operating Income | -$1.5M | $1.7M | -$5.4M | -$2.9M | -$6.3M | |
| Net Interest Expenses | $405K | $517K | $936K | $1.3M | $711K | |
| EBT. Incl. Unusual Items | -$2.5M | $110K | -$34.9M | -$8M | -$7.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$3M | -$1.2M | -$35K | -$12K | |
| Net Income to Company | -$2.5M | $3.1M | -$33.6M | -$7.9M | -$7.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.5M | $3.1M | -$33.6M | -$7.9M | -$7.6M | |
| Basic EPS (Cont. Ops) | -$0.18 | $0.23 | -$2.43 | -$0.48 | -$0.27 | |
| Diluted EPS (Cont. Ops) | -$0.18 | $0.23 | -$2.43 | -$0.48 | -$0.27 | |
| Weighted Average Basic Share | $13.4M | $13.6M | $13.8M | $16.5M | $28.1M | |
| Weighted Average Diluted Share | $13.4M | $13.6M | $13.8M | $16.5M | $28.1M | |
| EBITDA | $1.7M | $5.1M | -$2.7M | -$531K | -$3.8M | |
| EBIT | -$1.5M | $1.7M | -$5.4M | -$2.9M | -$6.3M | |
| Revenue (Reported) | $85.9M | $89M | $66.2M | $64.5M | $47M | |
| Operating Income (Reported) | -$1.5M | $1.7M | -$5.4M | -$2.9M | -$6.3M | |
| Operating Income (Adjusted) | -$1.5M | $1.7M | -$5.4M | -$2.9M | -$6.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $311.4M | $376.3M | $310.3M | $262M | $212.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $241.9M | $287.3M | $243.9M | $204.5M | $175.7M | |
| Gross Profit | $69.5M | $89.1M | $66.4M | $57.5M | $36.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $14.7M | $18.4M | $18.2M | $18.1M | $12.6M | |
| Selling, General & Admin | $61.4M | $61.8M | $62.6M | $57.2M | $50M | |
| Other Inc / (Exp) | -$3.3M | -$55.6M | -$124.4M | -$2.9M | -- | |
| Operating Expenses | $70.9M | $76.8M | $75.1M | $71.4M | $59.4M | |
| Operating Income | -$1.4M | $12.3M | -$8.7M | -$14M | -$22.7M | |
| Net Interest Expenses | $3M | $1.7M | $3.1M | $4.5M | $3.3M | |
| EBT. Incl. Unusual Items | -$13M | -$49.6M | -$128.6M | -$28.3M | -$28.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $756K | $2.4M | $208K | -$569K | -$1.8M | |
| Net Income to Company | -$13.7M | -$52M | -$128.8M | -$27.7M | -$26.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.7M | -$52M | -$128.8M | -$27.7M | -$26.5M | |
| Basic EPS (Cont. Ops) | -$1.02 | -$3.83 | -$9.42 | -$1.82 | -$1.15 | |
| Diluted EPS (Cont. Ops) | -$1.02 | -$3.83 | -$9.42 | -$1.82 | -$1.15 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $12.4M | $25.6M | $2.6M | -$3.7M | -$12.9M | |
| EBIT | -$1.4M | $12.3M | -$8.7M | -$14M | -$22.7M | |
| Revenue (Reported) | $311.4M | $376.3M | $310.3M | $262M | $212.4M | |
| Operating Income (Reported) | -$1.4M | $12.3M | -$8.7M | -$14M | -$22.7M | |
| Operating Income (Adjusted) | -$1.4M | $12.3M | -$8.7M | -$14M | -$22.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $229.4M | $276.5M | $225.6M | $189.2M | $146.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $174.6M | $211.7M | $176.1M | $149.8M | $121.8M | |
| Gross Profit | $54.8M | $64.8M | $49.6M | $39.4M | $25.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.3M | $14M | $14.1M | $13.7M | $9M | |
| Selling, General & Admin | $45.5M | $46.4M | $38.4M | $41.7M | $36.7M | |
| Other Inc / (Exp) | -$3.3M | -$55.5M | -$55.4M | -$6.1M | -$80K | |
| Operating Expenses | $63.1M | $57.4M | $56.3M | $52.3M | $43.3M | |
| Operating Income | -$8.3M | $7.4M | -$6.8M | -$12.9M | -$18.1M | |
| Net Interest Expenses | $1.8M | $1.3M | $2.4M | $3.7M | $2.3M | |
| EBT. Incl. Unusual Items | -$13.9M | -$53.7M | -$60.8M | -$25.7M | -$22.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1K | $2.1M | $551K | $98K | $114K | |
| Net Income to Company | -$13.9M | -$55.8M | -$61.3M | -$25.8M | -$23M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.9M | -$55.8M | -$61.3M | -$25.8M | -$23M | |
| Basic EPS (Cont. Ops) | -$1.02 | -$4.11 | -$4.47 | -$1.68 | -$0.96 | |
| Diluted EPS (Cont. Ops) | -$1.02 | -$4.11 | -$4.47 | -$1.68 | -$0.96 | |
| Weighted Average Basic Share | $40.3M | $40.7M | $41.3M | $45.9M | $73.4M | |
| Weighted Average Diluted Share | $40.3M | $40.7M | $41.3M | $45.9M | $73.4M | |
| EBITDA | -$1.5M | $17.4M | $1.3M | -$5.4M | -$10.7M | |
| EBIT | -$11.5M | $7.4M | -$6.8M | -$12.9M | -$18.1M | |
| Revenue (Reported) | $229.4M | $276.5M | $225.6M | $189.2M | $146.9M | |
| Operating Income (Reported) | -$8.3M | $7.4M | -$6.8M | -$12.9M | -$18.1M | |
| Operating Income (Adjusted) | -$11.5M | $7.4M | -$6.8M | -$12.9M | -$18.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $21.1M | $34.5M | $25.5M | $15.8M | $10.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $62.7M | $70.2M | $63.2M | $56.5M | $46.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.4M | $2.5M | $3.5M | $6.1M | $8.7M | |
| Total Current Assets | $86.2M | $107.2M | $92.2M | $78.4M | $66M | |
| Property Plant And Equipment | $10.5M | $8.3M | $6.2M | $4M | $1.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $165.1M | $165.1M | $55.1M | $1.3M | -- | |
| Other Intangibles | $45.4M | $35.7M | $28.7M | $26.8M | $21.8M | |
| Other Long-Term Assets | $3M | $1.9M | $1.7M | $1.4M | $4M | |
| Total Assets | $310.2M | $318.2M | $184M | $111.9M | $93.6M | |
| Accounts Payable | $7.7M | $16.1M | $6.2M | $11M | $8.8M | |
| Accrued Expenses | $31.6M | $33.9M | $35.6M | $30.5M | $21.9M | |
| Current Portion Of Long-Term Debt | $7.3M | $5M | $5M | $5M | $31.6M | |
| Current Portion Of Capital Lease Obligations | $2.3M | $2.2M | $2.4M | $2.3M | $1.8M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $50.2M | $57.9M | $50.2M | $49.2M | $64.7M | |
| Long-Term Debt | $33.3M | $46M | $39.3M | $27.2M | $4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $93.3M | $104.8M | $90M | $77.5M | $68.7M | |
| Common Stock | $40K | $42K | $42K | $43K | $47K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $216.9M | $213.4M | $94M | $34.4M | $25M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $216.9M | $213.4M | $94M | $34.4M | $25M | |
| Total Liabilities and Equity | $310.2M | $318.2M | $184M | $111.9M | $93.6M | |
| Cash and Short Terms | $21.1M | $34.5M | $25.5M | $15.8M | $10.7M | |
| Total Debt | $40.6M | $51M | $44.3M | $32.2M | $35.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.6M | $33.1M | $20.5M | $6.6M | $9.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $76.6M | $67.6M | $48.5M | $52.6M | $32.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.2M | $2.3M | $8.1M | $7.1M | -- | |
| Total Current Assets | $94.4M | $103M | $77.1M | $66.3M | $49.5M | |
| Property Plant And Equipment | $8.7M | $6.7M | $4.5M | $2.4M | $3.2M | |
| Long-Term Investments | $1.5M | -- | -- | $1.3M | $710K | |
| Goodwill | $165.1M | $110.8M | $1.3M | -- | -- | |
| Other Intangibles | $38.1M | $30.7M | $27.7M | $22.7M | -- | |
| Other Long-Term Assets | $3.3M | $1.8M | $1.5M | $4.6M | -- | |
| Total Assets | $309.5M | $253M | $112.1M | $95.9M | $76.1M | |
| Accounts Payable | $16.2M | $14.9M | $11.8M | $7.9M | $9.4M | |
| Accrued Expenses | $28.9M | $27.6M | $25.7M | $27.3M | -- | |
| Current Portion Of Long-Term Debt | $5M | $5M | $31.8M | $32.6M | -- | |
| Current Portion Of Capital Lease Obligations | $2.2M | $2.4M | $2.3M | $2.2M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $53M | $51.2M | $72.2M | $70.4M | $48.4M | |
| Long-Term Debt | $47.5M | $41M | $2.2M | $5.5M | $6.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $101.2M | $93M | $76.6M | $76M | $54.5M | |
| Common Stock | $42K | $42K | $43K | $46K | $53K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $208.4M | $160M | $35.5M | $20M | $21.6M | |
| Total Liabilities and Equity | $309.5M | $253M | $112.1M | $95.9M | $76.1M | |
| Cash and Short Terms | $15.6M | $33.1M | $20.5M | $6.6M | $9.2M | |
| Total Debt | $54.7M | $46M | $34M | $38.1M | $28.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2M | -$10.1M | -$123.3M | -$63.2M | -$29.3M | |
| Depreciation & Amoritzation | $15.3M | $13.2M | $13.2M | $10.9M | $9.9M | |
| Stock-Based Compensation | $5.4M | $4.8M | $4.1M | $3.8M | $2M | |
| Change in Accounts Receivable | -$2M | -$7.7M | $6.6M | $6.5M | $9.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $20.3M | $12.4M | $2M | $7.6M | -$16M | |
| Capital Expenditures | $2.8M | $3M | $4.4M | $5.9M | $6.2M | |
| Cash Acquisitions | -$1.4M | -- | $1M | $1.3M | -- | |
| Cash From Investing | -$4.3M | -$3M | -$5.4M | -$7.1M | -$6.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $49.6M | -- | -- | $67.5M | |
| Long-Term Debt Repaid | -$11.8M | -$47.5M | -$5M | -$10M | -$68.2M | |
| Repurchase of Common Stock | -$1.3M | -- | -- | -- | -- | |
| Other Financing Activities | -$515K | -$724K | -$448K | -$768K | -$2.4M | |
| Cash From Financing | -$13.6M | $2.5M | -$5.4M | -$10.2M | $17.1M | |
| Beginning Cash (CF) | $20.2M | $34.5M | $25.5M | $15.8M | $10.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4M | $11.9M | -$8.9M | -$9.7M | -$5.1M | |
| Ending Cash (CF) | $22.6M | $46.4M | $16.6M | $6.1M | $5.6M | |
| Levered Free Cash Flow | $17.5M | $9.4M | -$2.4M | $1.7M | -$22.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.5M | $3.1M | -$33.6M | -$7.9M | -$7.6M | |
| Depreciation & Amoritzation | $3.2M | $3.4M | $2.7M | $2.4M | $2.5M | |
| Stock-Based Compensation | $1.1M | $801K | $961K | $460K | $478K | |
| Change in Accounts Receivable | -$10.7M | $10.3M | $9.6M | $2.1M | -$861K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.3M | $9.1M | $7.5M | $579K | -$7.6M | |
| Capital Expenditures | $705K | $1.1M | $1.7M | $1.2M | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$705K | -$1.1M | -$1.7M | -$1.2M | -$1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $13.8M | -- | |
| Long-Term Debt Repaid | -$2.5M | -$1.3M | -$6.3M | -$11.7M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$52K | -- | -$138K | -$657K | -- | |
| Cash From Financing | -$2.6M | -$1.3M | -$6.3M | $2M | $11.9M | |
| Beginning Cash (CF) | $15.6M | $33.1M | $20.5M | $6.6M | $9.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$9.5M | $6.7M | -$470K | $1.4M | $2.6M | |
| Ending Cash (CF) | $6.1M | $39.8M | $20M | $8M | $11.9M | |
| Levered Free Cash Flow | -$7M | $8M | $5.8M | -$607K | -$9.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.7M | -$52M | -$128.8M | -$27.7M | -$26.5M | |
| Depreciation & Amoritzation | $13.7M | $13.3M | $11.3M | $10.3M | $9.8M | |
| Stock-Based Compensation | $4.1M | $3.8M | $4.4M | $2.3M | $1.6M | |
| Change in Accounts Receivable | -$17.4M | $8.8M | $18.9M | -$4.8M | $20.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $505K | $26.5M | $4.2M | -$15.3M | -$7M | |
| Capital Expenditures | $3.1M | $4.1M | $5.2M | $6.5M | $6.4M | |
| Cash Acquisitions | -- | $971K | $1.3M | -- | -- | |
| Cash From Investing | -$3.1M | -$5M | -$6.5M | -$6.5M | -$6.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $49.6M | -- | -- | $56.7M | -- | |
| Long-Term Debt Repaid | -$47.1M | -$5M | -$10M | -$57.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$744K | -$453K | -$611K | -$1.8M | -- | |
| Cash From Financing | $2.8M | -$5.5M | -$10.2M | $9.1M | $15.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $221K | $16M | -$12.6M | -$12.7M | $2.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.6M | $22.4M | -$1M | -$21.8M | -$13.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.9M | -$55.8M | -$61.3M | -$25.8M | -$23M | |
| Depreciation & Amoritzation | $9.9M | $10M | $8.1M | $7.5M | $7.4M | |
| Stock-Based Compensation | $3.6M | $2.7M | $3M | $1.5M | $1.1M | |
| Change in Accounts Receivable | -$14M | $2.4M | $14.7M | $3.4M | $14.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.9M | $7.1M | $9.3M | -$13.6M | -$4.6M | |
| Capital Expenditures | $2.3M | $3.3M | $4.1M | $4.7M | $4.9M | |
| Cash Acquisitions | -- | $971K | $1.3M | -- | -- | |
| Cash From Investing | -$2.3M | -$4.3M | -$5.4M | -$4.7M | -$4.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $49.6M | -- | -- | $56.7M | $21.8M | |
| Long-Term Debt Repaid | -$46.3M | -$3.8M | -$8.8M | -$56.2M | -$31.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$719K | -$448K | -$611K | -$1.6M | -$125K | |
| Cash From Financing | $3.7M | -$4.2M | -$9M | $10.4M | $8.8M | |
| Beginning Cash (CF) | $72.3M | $88.4M | $68.1M | $23.2M | $21.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$5.5M | -$1.4M | -$5M | -$8M | -$737K | |
| Ending Cash (CF) | $66.9M | $87.1M | $63M | $15.3M | $21.2M | |
| Levered Free Cash Flow | -$9.2M | $3.8M | $5.2M | -$18.3M | -$9.5M | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.